As of 2025-11-07, the Relative Valuation of Revolution Medicines Inc (RVMD) is (48.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 59.34 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -182.5%.
The range of the Relative Valuation is (39.29) - (55.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 17.4x | 15.3x |
| Forward P/E multiples | 12.2x - 19.1x | 15.2x |
| Fair Price | (39.29) - (55.99) | (48.96) |
| Upside | -166.2% - -194.3% | -182.5% |
| Date | P/E |
| 2025-11-05 | -18.48 |
| 2025-11-04 | -18.24 |
| 2025-11-03 | -18.48 |
| 2025-10-31 | -18.33 |
| 2025-10-30 | -18.34 |
| 2025-10-29 | -18.07 |
| 2025-10-28 | -18.12 |
| 2025-10-27 | -18.06 |
| 2025-10-24 | -16.97 |
| 2025-10-23 | -16.65 |
| 2025-10-22 | -16.50 |
| 2025-10-21 | -16.66 |
| 2025-10-20 | -16.82 |
| 2025-10-17 | -16.85 |
| 2025-10-16 | -15.48 |
| 2025-10-15 | -15.44 |
| 2025-10-14 | -14.80 |
| 2025-10-13 | -15.19 |
| 2025-10-10 | -15.03 |
| 2025-10-09 | -14.83 |
| 2025-10-08 | -14.90 |
| 2025-10-07 | -14.51 |
| 2025-10-06 | -14.51 |
| 2025-10-03 | -14.55 |
| 2025-10-02 | -14.24 |
| 2025-10-01 | -14.29 |
| 2025-09-30 | -14.55 |
| 2025-09-29 | -14.35 |
| 2025-09-26 | -13.68 |
| 2025-09-25 | -13.24 |
| 2025-09-24 | -13.56 |
| 2025-09-23 | -13.77 |
| 2025-09-22 | -13.83 |
| 2025-09-19 | -13.56 |
| 2025-09-18 | -14.09 |
| 2025-09-17 | -13.65 |
| 2025-09-16 | -13.92 |
| 2025-09-15 | -14.39 |
| 2025-09-12 | -14.50 |
| 2025-09-11 | -14.40 |
| 2025-09-10 | -12.60 |
| 2025-09-09 | -12.75 |
| 2025-09-08 | -12.79 |
| 2025-09-05 | -12.62 |
| 2025-09-04 | -12.13 |
| 2025-09-03 | -12.39 |
| 2025-09-02 | -12.31 |
| 2025-08-29 | -11.83 |
| 2025-08-28 | -11.94 |
| 2025-08-27 | -11.85 |